Leukemia diagnosis: today and tomorrow

被引:21
作者
Bene, Marie C. [1 ]
Grimwade, David [2 ]
Haferlach, Claudia [3 ]
Haferlach, Torsten [3 ]
Zini, Gina [4 ]
机构
[1] Univ Hosp, Hematol Biol, Nantes, France
[2] Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England
[3] MLL, Munich, Germany
[4] Univ Cattolica Sacro Cuore, Hematol & Clin Pathol, I-00168 Rome, Italy
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SUB-SAHARAN AFRICA; MYELODYSPLASTIC SYNDROMES; SCORING SYSTEM; EUROPEAN LEUKEMIANET; FLOW-CYTOMETRY; WORKING GROUP;
D O I
10.1111/ejh.12603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly involved in the various aspects of diagnosis. On the occasion of the annual ELN meeting of 2015 in Mannheim, these four work packages collectively examined the current situation and future prospects of cytomorphology, flow cytometry, cytogenetics, next-generation sequencing, and minimal residual disease detection in the context of leukemia diagnosis and follow-up. This document summarizes the outcome of this compendium.
引用
收藏
页码:365 / 373
页数:9
相关论文
共 59 条
  • [1] [Anonymous], 1986, CANCER GENET CYTOGEN, V23, P189
  • [2] [Anonymous], ASH ANN M
  • [3] Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
    Bene, M. C.
    Nebe, T.
    Bettelheim, P.
    Buldini, B.
    Bumbea, H.
    Kern, W.
    Lacombe, F.
    Lemez, P.
    Marinov, I.
    Matutes, E.
    Maynadie, M.
    Oelschlagel, U.
    Orfao, A.
    Schabath, R.
    Solenthaler, M.
    Tschurtschenthaler, G.
    Vladareanu, A. M.
    Zini, G.
    Faure, G. C.
    Porwit, A.
    [J]. LEUKEMIA, 2011, 25 (04) : 567 - 574
  • [4] BENE MC, 1995, LEUKEMIA, V9, P1783
  • [5] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, HR
    SULTAN, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) : 451 - &
  • [6] BERNARD A, 1984, PRESSE MED, V13, P2311
  • [7] Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia
    Bradbury, C.
    Houlton, A. E.
    Akiki, S.
    Gregg, R.
    Rindl, M.
    Khan, J.
    Ward, J.
    Khan, N.
    Griffiths, M.
    Nagra, S.
    Hills, R.
    Burnett, A.
    Russell, N.
    Vyas, P.
    Grimwade, D.
    Craddock, C.
    Freeman, S. D.
    [J]. LEUKEMIA, 2015, 29 (04) : 988 - 991
  • [8] The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
    Cornelissen, Jan J.
    Gratwohl, Alois
    Schlenk, Richard F.
    Sierra, Jorge
    Bornhaeuser, Martin
    Juliusson, Gunnar
    Racil, Zdenek
    Rowe, Jacob M.
    Russell, Nigel
    Mohty, Mohamad
    Lowenberg, Bob
    Socie, Gerard
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (10) : 579 - 590
  • [9] Should evaluation for minimal residual disease be routine in acute myeloid leukemia?
    Coustan-Smith, Elaine
    Campana, Dario
    [J]. CURRENT OPINION IN HEMATOLOGY, 2013, 20 (02) : 86 - 92
  • [10] Validation of Cell-Based Fluorescence Assays: Practice Guidelines from the International Council for Standardization of Haematology and International Clinical Cytometry Society
    Davis, Bruce H.
    Dasgupta, Amar
    Kussick, Steven
    Han, Jin-Yeong
    Estrellado, Annalee
    O'Neil, Patrick
    Hoffman, Bob
    Purvis, Norman
    Hunsberger, Ben
    Vall, Horacio
    Kaplan, David
    Wang, Lili
    Porwit, Anna
    Tanqri, Shabnam
    Shankey, T. Vincent
    Barnett, David
    Louzao, Raul
    Gambell, Peter
    De, Jitakshi
    Oldaker, Teri
    Hanson, Curtis
    Wood, Brent L.
    Jevremovic, Dragan
    Bene, Marie C.
    Yan, Ming
    Jacobs, Patrick
    Litwin, Virginia
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84 (05) : 281 - 281